191 related articles for article (PubMed ID: 32628430)
1. Intracellular signaling modules linking DNA damage to secretome changes in senescent melanoma cells.
Chavanet A; Hill KR; Jiménez-Andrade Y; Choo MK; White K; Park JM
Melanoma Res; 2020 Aug; 30(4):336-347. PubMed ID: 32628430
[TBL] [Abstract][Full Text] [Related]
2. Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS).
Ohanna M; Giuliano S; Bonet C; Imbert V; Hofman V; Zangari J; Bille K; Robert C; Bressac-de Paillerets B; Hofman P; Rocchi S; Peyron JF; Lacour JP; Ballotti R; Bertolotto C
Genes Dev; 2011 Jun; 25(12):1245-61. PubMed ID: 21646373
[TBL] [Abstract][Full Text] [Related]
3. Mitofusin 1 silencing decreases the senescent associated secretory phenotype, promotes immune cell recruitment and delays melanoma tumor growth after chemotherapy.
Tarallo D; Martínez J; Leyva A; Mónaco A; Perroni C; Tassano M; Gambini JP; Cappetta M; Durán R; Moreno M; Quijano C
Sci Rep; 2024 Jan; 14(1):909. PubMed ID: 38195762
[TBL] [Abstract][Full Text] [Related]
4. The lysosomal proteome of senescent cells contributes to the senescence secretome.
Rovira M; Sereda R; Pladevall-Morera D; Ramponi V; Marin I; Maus M; Madrigal-Matute J; Díaz A; García F; Muñoz J; Cuervo AM; Serrano M
Aging Cell; 2022 Oct; 21(10):e13707. PubMed ID: 36087066
[TBL] [Abstract][Full Text] [Related]
5. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
[TBL] [Abstract][Full Text] [Related]
6. Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer.
Loo TM; Miyata K; Tanaka Y; Takahashi A
Cancer Sci; 2020 Feb; 111(2):304-311. PubMed ID: 31799772
[TBL] [Abstract][Full Text] [Related]
7. Proteomics Approaches to Define Senescence Heterogeneity and Chemotherapy Response.
Petit C; Guillon J; Toutain B; Boissard A; Patsouris A; Lelièvre E; Guette C; Coqueret O
Proteomics; 2019 Nov; 19(21-22):e1800447. PubMed ID: 30968557
[TBL] [Abstract][Full Text] [Related]
8. Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression.
Mackenzie Ross AD; Cook MG; Chong H; Hossain M; Pandha HS; Bennett DC
Pigment Cell Melanoma Res; 2013 Mar; 26(2):226-35. PubMed ID: 23253087
[TBL] [Abstract][Full Text] [Related]
9. Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.
Giuliano S; Cheli Y; Ohanna M; Bonet C; Beuret L; Bille K; Loubat A; Hofman V; Hofman P; Ponzio G; Bahadoran P; Ballotti R; Bertolotto C
Cancer Res; 2010 May; 70(9):3813-22. PubMed ID: 20388797
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP).
Salminen A; Kauppinen A; Kaarniranta K
Cell Signal; 2012 Apr; 24(4):835-45. PubMed ID: 22182507
[TBL] [Abstract][Full Text] [Related]
11. Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest.
Bailet O; Fenouille N; Abbe P; Robert G; Rocchi S; Gonthier N; Denoyelle C; Ticchioni M; Ortonne JP; Ballotti R; Deckert M; Tartare-Deckert S
Cancer Res; 2009 Apr; 69(7):2748-56. PubMed ID: 19293188
[TBL] [Abstract][Full Text] [Related]
12. Wnt signaling potentiates nevogenesis.
Pawlikowski JS; McBryan T; van Tuyn J; Drotar ME; Hewitt RN; Maier AB; King A; Blyth K; Wu H; Adams PD
Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16009-14. PubMed ID: 24043806
[TBL] [Abstract][Full Text] [Related]
13. IFI16, an amplifier of DNA-damage response: Role in cellular senescence and aging-associated inflammatory diseases.
Choubey D; Panchanathan R
Ageing Res Rev; 2016 Jul; 28():27-36. PubMed ID: 27063514
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and Regulation of Cellular Senescence.
Roger L; Tomas F; Gire V
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884978
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma.
Homann L; Rentschler M; Brenner E; Böhm K; Röcken M; Wieder T
Cells; 2022 Apr; 11(9):. PubMed ID: 35563820
[TBL] [Abstract][Full Text] [Related]
16. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.
Muñoz DP; Yannone SM; Daemen A; Sun Y; Vakar-Lopez F; Kawahara M; Freund AM; Rodier F; Wu JD; Desprez PY; Raulet DH; Nelson PS; van 't Veer LJ; Campisi J; Coppé JP
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184599
[TBL] [Abstract][Full Text] [Related]
17. TNFα-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion.
Kandhaya-Pillai R; Miro-Mur F; Alijotas-Reig J; Tchkonia T; Kirkland JL; Schwartz S
Aging (Albany NY); 2017 Nov; 9(11):2411-2435. PubMed ID: 29176033
[TBL] [Abstract][Full Text] [Related]
18. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.
Fan T; Jiang S; Chung N; Alikhan A; Ni C; Lee CC; Hornyak TJ
Mol Cancer Res; 2011 Apr; 9(4):418-29. PubMed ID: 21383005
[TBL] [Abstract][Full Text] [Related]
19. Ataxia telangiectasia mutated (ATM)-mediated DNA damage response in oxidative stress-induced vascular endothelial cell senescence.
Zhan H; Suzuki T; Aizawa K; Miyagawa K; Nagai R
J Biol Chem; 2010 Sep; 285(38):29662-70. PubMed ID: 20639198
[TBL] [Abstract][Full Text] [Related]
20. Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.
Nadeau S; Cheng A; Colmegna I; Rodier F
Methods Mol Biol; 2019; 2045():93-105. PubMed ID: 31020633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
